FULL PUBLICATIONS: +, equal contribution; *,corresponding author

25. Wu C+, Lin J+, Chen Y, Takahashi N, Chen Q, Liu B, Dai F, Zhao W, Finkelstein D, Kawahata I*, Fukunaga K*, Cheng A*Astrocytic FABP5 drives non-cell-autonomous oligodendrocyte injury in multiple system atrophy by promoting TNF signaling and ferroptotic stress. BioRxiv /2025/687320. doi: https://doi.org/10.1101/2025.11.08.687320. (最后通讯作者) 

24. Wu C+, Lin J+, Chen Q, Zhao W, Kawahata I, Cheng A*. Targeting the FABP Axis: A Review of the Interplay between Lipid Metabolism, Neuroinflammation, and Neurodegeneration. Cells (2025), 14(19), 1502. (Invited Review) (最后通讯作者,中科院区,IF=5.2) 

23. Cheng A*, Fukunaga K, Lakkaraju A. Feasibility and considerations of Epsin2 as a candidate target for multiple system atrophy treatment. Expert Opinion On Therapeutic Targets (2023) 27 (11), 1032-1034. (第一作者,最后通讯作者,中科院二区,IF=6.8) 

22. Tian Z*, Cheng A*. Myelin in white matter function and related diseases. Frontiers in Molecular Neuroscience (2023) 16:1284273. (最后通讯作者,中科院二区,IF=4.8) 

21. Cheng A+ *, Jia W+, Finkelstein D, Stefanova N, Wang H, Sasaki T, Kawahata I, Fukunaga K*. FABP7 inhibition for cerebellum ataxia: a pharmacological study in multiple system atrophy model mouse. Acta Pharmacologica Sinica (2024) 45 (1), 66-75. (第一作者,共同通讯作者,中科院一区,IF=8.2) 

20. Cheng A*, Kawahata I, Wang Y, Jia W, Wang H, Sekimori T, Chen Y, Suzuki H, Takeda A, Stefanova N, , Ma W, Chen M, Finkelstein D, Sasaki T*, Fukunaga K*. Epsin2, a novel target for multiple system atrophy therapy via regulating α-synuclein propagation associated with FABP7. Brain (2023) 146(8): 3172–3180.  (第一作者,共同通讯作者,中科院一区,IF=14.5) 

19. Jia W, Kawahata I, Cheng A, Sasaki T, Sasaoka T, Fukunaga K*. Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors by FABP3 Inhibitor in Mice. Int. J. Mol. Sci. (2023) 24(7): 6644. (合作作者,中科院区,IF=6.2) 

18. Wang H, Fukunaga K, Cheng A, Wang Y, Arimura N, Yoshino H, Sasaki T, Kawahata I*. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice. Journal of Pharmacological Sciences (2023) 152: 30-8. (合作作者,中科院区,IF=3.6) 

17. Guo Q, Kawahata I*, Jia W, Wang H, Cheng A, Yabuki, Shioda N, Fukunaga K*. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss. CNS Neurosci Ther. (2023) 29: 1547-1560. (合作作者,中科院区,IF=7.2) 

16. Guo Q, Kawahata I*, Cheng A, Wang H, Jia W, Yoshino H, Fukunaga K*. Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons. Redox Biology (2023) 59: 102547. (合作作者,中科院一区,IF=10.8) 

15. Ma W*, Wang Y, Li B, Zhou Y, Xu Y, Sun Y, Gu L*, Cheng A. Rhodium-Catalyzed Oxidative Coupling of Potassium Vinyltrifluoroborate with Arenes: A Direct Access to Functionalized Styrene Derivatives. Advanced Synthesis & Catalysis (2022) 364(22): 3881-3887. (合作作者,中科院区,IF=5.98) 

14. Cheng A*, Fukunaga K. Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies. Nihon Yakurigaku zasshi. Folia Pharmacologica Japonica (2022) 157(6): 396-400. (第一作者,共同通讯作者,日文) 

13. Cheng A, Wang Y, Shinoda Y, Kawahata I, Yamamoto T, Jia W, Yamamoto H, Mizobata T, Kawata Y, Fukunaga K. Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress. Acta Pharmacologica Sinica (2022) 43(3): 552-562. (第一作者,中科院区,IF=8.2) 

12. Guo Q*, Kawahata I, Cheng A, Jia W, Wang H and Fukunaga K*. Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets. Int. J. Mol. Sci. (2022) 23(17): 9648.  (合作作者,中科院二区,IF=6.2)

11. Cheng A, Jia W, Kawahata I, Fukunaga K*. A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse model. eBioMedicine (2021) 72: 103582. (第一作者,中科院一区,IF=11.2) 

10. Ma W*, Tan Y, Wang Y, Li Z, Li Z, Gu L, Mei R, Cheng A. Hydroxyl-Directed Ruthenium-Catalyzed peri-Selective C-H Acylmethylation and Annulation of Naphthols with Su oxonium Ylides. Org. Lett. (2021) 23: 6200–6205. (合作作者,中科院一区,IF=6.1) 

9. Cheng A, Kawahata I, Jia W, Fukunaga K*. Impact of Fatty Acid-Binding Proteins in alpha- Synuclein-Induced Mitochondrial Injury in Synucleinopathy. Biomedicines (2021) 9: 560. (第一作者,中科院区,IF=6.1)

8. Jia W, Kawahata I, Cheng A, Fukunaga K*. The Role of CaMKII and ERK Signaling in Addiction. Int. J. Mol. Sci. (2021) 22(6): 3189. (合作作者,中科院二区,IF=6.2)

7. Umaru BA, Kagawa Y, Shil SK, Arakawa N, Pan Y, Miyazaki H, Kobayashi S, Yang S, Cheng A, Wang Y, Shinoda Y, Kiniwa Y, Okuyama R, Fukunaga K, Owada Y*. Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling. Pharm Res. (2021) 38(3): 479-90. (合作作者,中科院二区,IF=5.2)

6. Wang Y, Shinoda Y, Cheng A, Kawahata I, Fukunaga K*. Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury Under Oxidative Stress. Biomedicines (2021) 9: 110. (合作作者,中科院三区,IF=6.1)

5. Yuan D, Cheng A, Kawahata I, Izumi H, Xu J, and Fukunaga K*. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice. Int. J. Mol. Sci. (2021) 22(2): 741. (合作作者,中科院二区,IF=6.2)

4. Jia W, Wilar G, Kawahata I, Cheng A, and Fukunaga K*. Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice. Molecular neurobiology (2021) 58: 2030-2045. (合作作者,中科院二区,IF=5.7)

3. Cheng A, Kawahata I, and Fukunaga K*. Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes. Biomedicines (2020) 8: 635. (第一作者,中科院三区,IF=6.1)

2. Matsuo K, Cheng A, Yabuki Y, Takahata I, Miyachi H, and Fukunaga K*. Inhibition of MPTP- induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice. Neuropharmacology (2019) 150: 164-74. (合作作者,中科院区,IF=5.2)

1. Cheng A+, Shinoda Y+, Yamamoto T, Miyachi H, Fukunaga K*. Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization. Brain research (2019) 1707: 190-7. (第一作者,中科院区,IF=3.1)